Rhythm Pharmaceuticals Inc (RYTM) returns
Rhythm Pharmaceuticals returns over 5 years
$1,000 invested in Rhythm Pharmaceuticals five years ago was worth $8,043 at the close on October 30, 2026, with dividends reinvested: an average return of 51.7% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -2.8% | — | $972.22 | -0.9% |
| 3 months | -12.5% | — | $875.45 | +2.1% |
| Year to date | -13.5% | — | $864.82 | +11.7% |
| 1 year | -17.2% | — | $827.92 | +12.4% |
| 3 years | +306.5% | +59.6% | $4,065 | +88.5% |
| 5 years | +704.3% | +51.7% | $8,043 | +76.0% |
Rhythm Pharmaceuticals return by calendar year
| Year | RYTM | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -13.5% | +11.7% | -25.2% |
| 2025 | +91.2% | +17.7% | +73.5% |
| 2024 | +21.8% | +24.9% | -3.1% |
| 2023 | +57.9% | +26.2% | +31.7% |
| 2022 | +191.8% | -18.2% | +210.0% |
| 2021 | -66.4% | +28.7% | -95.2% |
| 2020 | +29.5% | +18.4% | +11.1% |
| 2019 | -14.6% | +31.2% | -45.8% |
| 2018 | -7.5% | -4.6% | -2.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RYTM financials
No forecast, no recommendation. This page describes Rhythm Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.